相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Delivery of repurposed disulfiram by aminated mesoporous silica nanoparticles for anticancer therapy
Md Aquib et al.
JOURNAL OF MOLECULAR LIQUIDS (2022)
Recent advances in the design of choline kinase α inhibitors and the molecular basis of their inhibition
Belen Rubio-Ruiz et al.
MEDICINAL RESEARCH REVIEWS (2021)
Recent Advances in Cell Membrane-Derived Biomimetic Nanotechnology for Cancer Immunotherapy
Faisal Raza et al.
ADVANCED HEALTHCARE MATERIALS (2021)
Choline Kinase: An Unexpected Journey for a Precision Medicine Strategy in Human Diseases
Juan Carlos Lacal et al.
PHARMACEUTICS (2021)
ChoK-Full of Potential: Choline Kinase in B Cell and T Cell Malignancies
Samantha Gokhale et al.
PHARMACEUTICS (2021)
Recent progress on nanomedicine-induced ferroptosis for cancer therapy
Hajra Zafar et al.
BIOMATERIALS SCIENCE (2021)
Synthesis, biological evaluation, in silico modeling and crystallization of novel small monocationic molecules with potent antiproliferative activity by dual mechanism
Lucia Serran-Aguilera et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Biomimetic Magnetic Nanocarriers Drive Choline Kinase Alpha Inhibitor inside Cancer Cells for Combined Chemo-Hyperthermia Therapy
Ylenia Jabalera et al.
PHARMACEUTICS (2019)
Choline kinase inhibitors EB-3D and EB-3P interferes with lipid homeostasis in HepG2 cells
Alberto Sola-Leyva et al.
SCIENTIFIC REPORTS (2019)
EB-3D a novel choline kinase inhibitor induces deregulation of the AMPK-mTOR pathway and apoptosis in leukemia T-cells
Elena Mariotto et al.
BIOCHEMICAL PHARMACOLOGY (2018)
Lead optimization-hit expansion of new asymmetrical pyridinium/quinolinium compounds as choline kinase α1 inhibitors
Gianluca Rubbini et al.
FUTURE MEDICINAL CHEMISTRY (2018)
Choline Kinase Alpha Inhibition by EB-3D Triggers Cellular Senescence, Reduces Tumor Growth and Metastatic Dissemination in Breast Cancer
Elena Mariotto et al.
CANCERS (2018)
Design, synthesis, crystallization and biological evaluation of new symmetrical biscationic compounds as selective inhibitors of human Choline Kinase α1 (ChoKα1)
Santiago Schiaffino-Ortega et al.
SCIENTIFIC REPORTS (2016)
New more polar symmetrical bipyridinic compounds: new strategy for the inhibition of choline kinase α1
Francisco Fermin Castro-Navas et al.
FUTURE MEDICINAL CHEMISTRY (2015)
Design, Synthesis, in Vitro, and in Vivo Anticancer and Antiangiogenic Activity of Novel 3-Arylaminobenzofuran Derivatives Targeting the Colchicine Site on Tubulin
Romeo Romagnoli et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
A new family of choline kinase inhibitors with antiproliferative and antitumor activity derived from natural products
A. Estevez-Braun et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2015)
The Mechanism of Allosteric Coupling in Choline Kinase1 Revealed by the Action of a Rationally Designed Inhibitor
Maria Sahun-Roncero et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2013)
New non-symmetrical choline kinase inhibitors
Santiago Schiaffino-Ortega et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2013)
Determination of Potential Scaffolds for Human Choline Kinase 1 by Chemical Deconvolution Studies
Maria Sahun-Roncero et al.
CHEMBIOCHEM (2013)
Design, synthesis, theoretical calculations and biological evaluation of new non-symmetrical choline kinase inhibitors
Belen Rubio-Ruiz et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2012)
Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion
Ravid Straussman et al.
NATURE (2012)
The Kennedy pathway-De novo synthesis of phosphatidylethanolamine and phosphatidylcholine
Federica Gibellini et al.
IUBMB LIFE (2010)
Structure and function of pho sphatidylcho line transfer protein (PC-TP)/StarD2
Keishi Kanno et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2007)
Surflex-Dock 2.1: Robust performance from ligand energetic modeling, ring flexibility, and knowledge-based search
Ajay N. Jain
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2007)
Choline kinase: An important target for cancer
S Janardhan et al.
CURRENT MEDICINAL CHEMISTRY (2006)
Choline kinase inhibition induces the increase in ceramides resulting in a highly specific and selective cytotoxic antitumoral strategy as a potential mechanism of action
A Rodríguez-González et al.
ONCOGENE (2004)
Conformational dynamics of a bispyridinium cyclophane
A Conejo-García et al.
JOURNAL OF ORGANIC CHEMISTRY (2003)